Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Corami Therapeutics

Corami Therapeutics is an early-stage startup developing a combination platform drug delivery device and therapeutic hydrogels
2016
Gaussan, France

Innovation

Industry Problem

Current medications to treat atrial fibrillation have low success rates and potentially toxic side effects

R&D Focus

Drug delivery device and therapeutic hydrogels

Innovative Solution

Corami’s key innovation is a catheter device that allows therapeutic gels to be placed directly on the surface of the heart

Solution Effectiveness

Corami’s targeted delivery means the heart receives a sustained gel dose while minimizing side effects caused by a broader dosing approach

Investment Funding

Last Funding Stage

Grant

Total Funding Amount

$141.8K

Last Funding Amount

$41.9K

Last Funding Date

October 3, 2017

Startup Stage

Early Stage

People

Founders

Products

Demo Product or Complete Product?

Development

Something missing or incorrect on this page? Help us enrich this information